\def\countrylist{Angola, Benin, Botswana, Burkina Faso, Burundi, Cameroon, Cape Verde, Central African Republic, Chad, Comoros, Democratic Republic of the Congo, Djibouti, Equatorial Guinea, Eritrea, eSwatini, Ethiopia, The Gabon, Gambia, Ghana, Guinea, Guinea-Bissau, CÃ´te d'Ivoire, Kenya, Lesotho, Liberia, Madagascar, Malawi, Mali, Mauritania, Mauritius, Mozambique, Namibia, Niger, Nigeria, Republic of the Congo, Reunion, Rwanda, Sao Tome and Principe, Senegal, Seychelles, Sierra Leone, Somalia, South Africa, South Sudan, Sudan, Tanzania, Togo, Uganda, Zambia, Zimbabwe}
\def\bibidB{Salomon2005,Abbas2006,Granich2009,Hallett2009b,Bacaer2010,Pretorius2010,Metzger2011,Yusuf2012,Andrews2012,Granich2012,Wagner2012,Abbas2013,Long2013,Cremin2013,Alsallaq2013,Nichols2014,Nichols2014a,Alistar2014,Eaton2014a,Ying2015,Low2015,Khademi2015,Gilbert2015,Heaton2015,Rahman2016,Gilbert2016,Blaizot2016,Ying2016,Barnighausen2016,Heffernan2016,Maheu-Giroux2017a,Maheu-Giroux2017,Volz2017,Blaizot2017,Mukandavire2018,Guillon2018,Akudibillah2018,Stuart2018,deMontigny2018,Hauser2019}
\def\bibidAxB{Johnson2006,Baggaley2006,Wilson2006,Bacaer2008,Chigidi2009,Williams2010,Nyabadza2011,Barnighausen2012,Wagner2013,Decker2013,Wirtz2013,Shafer2014,Hove-Musekwa2014,Braithwaite2014,Nichols2014b,Abu-Raddad2014,Anderson2014,Alistar2014a,Cori2014,Stover2014,Wirtz2014,Korenromp2015,Knight2015,Kerr2015,Fraser2015,Kassa2015,Bekker2015,Shannon2015,Blaizot2015,Smith2016,Atun2016,Shattock2016,McGillen2016,Johnson2016,Sharma2016,Akudibillah2017,Alsallaq2017,Anderson2017,Chiu2017,Johnson2017b,Stuart2017,McGillen2017,Cremin2017,Ross2018,Anderson2018,Anderson2018a,Omondi2018,Woods2018,Stevens2018,Stopard2019,Beacroft2019a,Reidy2019,Omondi2019,Maheu-Giroux2019}
\def\plotlistdist{api.prev/HIV prevalence at $t_0$ (\%),api.inc/HIV incidence at $t_0$ (per 1000 PY),art.rbeta/Relative infectiousness on ART,act.n/Number of activity groups,age.n/Number of age groups,act.HRW.p/Proportion of women in the highest female activity group,act.HRM.p/Proportion of men in the client or highest activity male group,act.HRW.cr/Ratio of partners per year in the highest vs lowest female activity groups,act.HR.pr/Ratio of highest female to highest male activity group sizes,api.prev.cat/HIV prevalence at $t_0$ (\%),api.phase/HIV epidemic phase,Risk/Summary of risk heterogeneity,pt.def/Type of partnership definition}
\def\plotlistapi{api.prev/HIV prevalence at $t_0$ (\%),api.inc/HIV incidence at $t_0$ (per 1000 PY),api.phase/HIV epidemic phase,art.rbeta/Relative infectiousness on ART,art.cd4/CD4 initiation criteria,art.cov/ART coverage target,art.init/ART initiation rate (per PY),hiv.x.acute/Increased infectiousness during acute infection,hiv.x.late/Increased infectiousness during late-stage infection,hiv.morb.any/Decreased sexual activity during late-stage infection,art.tdr/Any transmitted drug resistance,art.fail.any/Any rate or state of ART failure,art.drop.any/Any rate or state of ART dropout,bc.any/Any behaviour change associated with diagnosis or ART,act.def.sex/Stratified by sex,Risk/Summary of risk heterogeneity,act.n/Number of activity groups,act.mix/Type of activity mixing,act.turn.any/Any activity group turnover,pt.def/Type of partnership definition,age.n/Number of age groups,age.mix/Type of age mixing,act.HRW.p/Proportion of women in the highest female activity group,act.HRM.p/Proportion of men in the client or highest activity male group,act.HRW.cr/Ratio of partners per year in the highest vs lowest female activity groups,act.HR.pr/Ratio of highest female to highest male activity group sizes}